The Exchange had sought clarification from Bodal Chemicals Limited for the quarter ended 31-Mar-2025 with respect to Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. On basis of above the Company was required to clarify the following: -1. Financial results submitted in XBRL with discrepancies The response of the Company is enclosed.
BODALCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
NSE had asked Bodal Chemicals to clarify discrepancies in the XBRL filing of its financial results for the quarter ended 31 March 2025. Specifically, the exchange noted that the company had marked the results as 'audited' in XBRL when corrections were needed. Bodal Chemicals has now re-submitted the revised standalone and consolidated financial results in XBRL format on 11 July 2025 and shared the acknowledgements with the exchange. The company considers this a compliance with the observation raised by NSE. This is a procedural correction to the filing format rather than a change in the underlying financial numbers.
This is a routine compliance correction with no impact on the company's actual financials, earnings, or shareholder value. Investors should view this as housekeeping rather than material news and wait for the original Q4 results for any fundamental takeaways.